ROFERON (RIFN-ALPHA(2A)) IS MORE IMMUNOGENIC THAN INTRON-A (RIFN-ALPHA(2B)) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

被引：30
|
作者：
VONWUSSOW, P
HEHLMANN, R
HOCHHAUS, T
JAKSCHIES, D
NOLTE, KU
PRUMMER, O
ANSARI, H
HASFORD, J
HEIMPEL, H
DEICHER, H
机构：
[1] UNIV HEIDELBERG, HOSP MED 3, DEPT HAEMATOL, D-69115 HEIDELBERG, GERMANY
[2] BIOMETR CTR THERAPEUT STUDIES, W-8000 MUNICH, GERMANY
[3] UNIV ULM, DEPT HAEMATOL ONCOL, W-7900 ULM, GERMANY
来源：
JOURNAL OF INTERFERON RESEARCH | 1994年 / 14卷 / 04期
关键词：
D O I：
10.1089/jir.1994.14.217
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：217 / 219
页数：3
相关论文
共 50 条
  • [31] RECOMBINANT ALPHA-2-B INTERFERON (INTRON-A) AS MAINTENANCE TREATMENT IN RESPONDING MM PATIENTS
    AVVISATI, G
    MANDELLI, F
    PETRUCCI, MT
    AMADORI, S
    TRIBALTO, M
    MARMONT, F
    BOCCADORO, M
    PILERI, A
    LAUTA, VM
    GERNONE, A
    DAMMACCO, F
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 313 - 314
  • [32] Combined alpha-interferon (rIFN alpha-2B) and low dose cytosine arabinoside (ARA-C) for PH+ chronic phase chronic myeloid leukemia (CML).
    Silver, RT
    Szatrowski, TP
    Peterson, B
    Powell, B
    Larson, R
    Stock, W
    Arthur, D
    Schiffer, C
    Bloomfield, CD
    [J]. BLOOD, 1996, 88 (10) : 2539 - 2539
  • [33] INTERFERON ALPHA-2B AS THERAPY FOR PATIENTS WITH PH'-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    ALIMENA, G
    MORRA, E
    LAZZARINO, M
    LIBERATI, AM
    MONTEFUSCO, E
    INVERARDI, D
    BERNASCONI, P
    MANCINI, M
    DONTI, E
    GRIGNANI, F
    BERNASCONI, C
    DIANZANI, F
    MANDELLI, F
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 : 25 - 28
  • [34] DIFFERENTIAL-EFFECTS OF TYROSINE KINASE INHIBITION IN CD69 ANTIGEN EXPRESSION AND LYTIC ACTIVITY-INDUCED BY RIL-2, RIL-12, AND RIFN-ALPHA IN HUMAN NK CELLS
    GEROSA, F
    TOMMASI, M
    BENATI, C
    GANDINI, G
    LIBONATI, M
    TRIDENTE, G
    CARRA, G
    TRINCHIERI, G
    [J]. CELLULAR IMMUNOLOGY, 1993, 150 (02) : 382 - 390
  • [35] Update of the 810 chronic myelogenous leukemia patients treated with interferon α2b or IFN α2b and Cytarabine
    Guilhot, F
    Maloisel, F
    Guerci, A
    Michallet, M
    Harousseau, JL
    Brière, J
    Rochant, H
    Ciurana, AJ
    Abgrall, JF
    Guyotat, D
    Christian, B
    Orfeuvre, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 282 - 283
  • [36] Results of a phase II trial testing interferon alpha 2b and cytarabine in children with chronic myelogenous leukemia.
    Millot, F
    Guilhot, J
    Nelken, B
    Lamagnére, JP
    Leblanc, T
    Leverger, G
    Notz, A
    Plantaz, D
    Bernard, F
    Bordigoni, P
    Yacouben, K
    Behar, C
    Thyss, A
    Guy, C
    Duchène, S
    Guilhot, F
    [J]. BLOOD, 2004, 104 (11) : 286A - 286A
  • [37] RENAL THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH INTERFERON-ALPHA-2B
    JADOUL, M
    PIESSEVAUX, H
    FERRANT, A
    COSYNS, JP
    DESTRIHOU, CV
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (01) : 111 - 113
  • [38] TREATMENT OF DECOMPENSATED CIRRHOSIS CHRONIC HEPATITIS-C (CIRR) WITH TITRATABLE REGIMEN OF RECOMBINANT ALPHA-INTERFERON-2B (RIFN)
    IVES, C
    TAYLOR, B
    BALART, L
    [J]. HEPATOLOGY, 1994, 19 (04) : I78 - I78
  • [39] The efficacy and side effects of interferon alpha 2a (Roferon) on chronic hepatitis B virus infection in Turkish children
    Kansu, A
    Altuntas, B
    Doganci, T
    Kalayci, AG
    Girgin, N
    [J]. HEPATOLOGY RESEARCH, 1999, 15 (01) : 1 - 9
  • [40] Should We Treat Chronic Hepatitis C in HIV with Peginterferon Alpha 2a or 2b?
    Garcia-Samaniego, Javier
    [J]. AIDS REVIEWS, 2010, 12 (01) : 60 - 61
12345